Lixte Biotechnology News

Express News | Lixte Biotechnology Holdings - on Dec 23, Eric Forman Resigns as Vp and COO of Lixte Biotech Effective as of Dec 31

ReutersDec 27, 2024 16:09 ET

10-Q: Q3 2024 Earnings Report

SECNov 12, 2024 16:54 ET · Announcements

Trending Stocks Today | GlycoMimetics Shoots up 227.4%

Moomoo NewsOct 29, 2024 14:00 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaOct 29, 2024 08:07 ET

Top Premarket Gainers

MT NewswiresOct 29, 2024 07:37 ET

Express News | Shuttle Pharmaceuticals shares surge 81% after it finalized agreements with all six planned site enrollment locations.

Moomoo 24/7Oct 29, 2024 06:16 ET

Trending Stocks Today | Lixte Biotechnology Surges 84.73% Pre-Market

Moomoo NewsOct 29, 2024 05:00 ET

Lixte Biotechnology Files to Sell Units, No Amount Given

TipRanksOct 23, 2024 06:15 ET

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

AccesswireSep 11, 2024 13:00 ET

Express News | LIXTE Biotechnology Receives USPTO Notice Of Allowance For Patent On Combining LB-100 With Cancer Immunotherapies, Strengthening Its Intellectual Property Portfolio And Advancing Cancer Treatment Trials

BenzingaSep 4, 2024 08:36 ET

Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

BenzingaAug 28, 2024 05:23 ET

Express News | Lixte Biotechnology Begins First Patient Dosing In New Clinical Trial With Netherlands Cancer Institute And Roche For Metastatic Colorectal Cancer

BenzingaAug 26, 2024 08:31 ET

First Patient Dosed With LIXTE's LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating With NKI, Supported by Major Pharma Company

GlobeNewswireAug 26, 2024 08:30 ET

Express News | First Patient Dosed With Lixte’s Lb-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating With Nki, Supported by Major Pharma Company

ReutersAug 26, 2024 08:30 ET

LIXTE Biotechnology Provides Update On Recent Activities And Developments; Collaboration With NKI And Funding Support For New Colorectal Cancer Clinical Trial By Major Pharma Co; Preclinical Data Published In Journal EMBO Reports Shows LB-100 As...

BenzingaAug 19, 2024 08:42 ET

Lixte Biotechnology Says Jan Schellens Joins Company as Chief Medical Officer >LIXT

Dow JonesAug 19, 2024 08:32 ET

Express News | Lixte Biotechnology Provides Update on Recent Activities and Developments

ReutersAug 19, 2024 08:30 ET

LIXTE Biotechnology Holdings to Present at Two Investor Conferences

GlobeNewswireAug 15, 2024 08:30 ET

Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event

AccesswireAug 14, 2024 22:50 ET

10-Q: Q2 2024 Earnings Report

SECAug 8, 2024 16:10 ET · Announcements